Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-Risk Cancer × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2587 Neoplasms 2112 Carcinoma, Non-Small-Cell Lung 1583 Prostatic Neoplasms 1414 Colorectal Neoplasms 1149 Lung Neoplasms 1075 Multiple Myeloma 800 Neoplasm Metastasis 788 Leukemia, Myeloid, Acute 745 Pancreatic Neoplasms 729 Ovarian Neoplasms 680 Melanoma 673 Carcinoma, Hepatocellular 622 Squamous Cell Carcinoma of Head and Neck 545 Brain Neoplasms 545 Stomach Neoplasms 542 Recurrence 541 Head and Neck Neoplasms 485 Glioblastoma 463 Lymphoma 457 Uterine Cervical Neoplasms 448 Precursor Cell Lymphoblastic Leukemia-Lymphoma 445 Carcinoma, Renal Cell 432 Triple Negative Breast Neoplasms 417 Endometrial Neoplasms 405 Urinary Bladder Neoplasms 392 Colonic Neoplasms 392 Hematologic Neoplasms 391 Lymphoma, Non-Hodgkin 374 Sarcoma 357

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡